ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Italy gives approval to trial osteoporosis drug for Covid-19 treatment
October 29, 2020The Italian Medicines Agency (AIFA) has granted approval to conduct human clinical trials on raloxifene, a generic osteoporosis drug to treat paucisymptomatic Covid-19 patients. -
FDA panel backs Amgen, UCB's postmenopausal osteoporosis drug Evenity
January 17, 2019An FDA advisory panel on Wednesday voted 18-1 that the benefits of Amgen and UCB's monthly injection Evenity (romosozumab) outweigh its risks for the treatment of osteoporosis in postmenopausal women at high risk for fracture. -
Osteoporosis drug may benefit heart health
May 16, 2018The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack and stroke…
Pharma Sources Insight January 2025
